Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOMARIN PHARMACEUTICAL INC Director's Dealing 2012

May 16, 2012

30583_dirs_2012-05-16_19ab0aac-a09b-4172-a7bc-079fbf05178d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2012-04-30

Reporting Person: Cooper Jeffrey H (SVP, Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-04-30 Common Stock A 985 $19.346 Acquired 41089 Direct
2012-05-14 Common Stock M 15000 $26.49 Acquired 56089 Direct
2012-05-14 Common Stock M 6500 $21.51 Acquired 62589 Direct
2012-05-14 Common Stock M 3750 $14.39 Acquired 66339 Direct
2012-05-14 Common Stock S 25250 $38.0878 Disposed 41089 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-05-14 Stock Option (right to buy) $26.49 M 15000 Disposed 2021-05-11 Common Stock (15000) Direct
2012-05-14 Stock Option (right to buy) $21.51 M 6500 Disposed 2020-05-11 Common Stock (6500) Direct
2012-05-14 Stock Option (right to buy) $14.39 M 3750 Disposed 2019-05-11 Common Stock (3750) Direct

Footnotes

F1: The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP period of November 1,2011 to April 30, 2012.

F2: Transaction made pursuant to a Rule 10b5-1 Trading plan executed March 6, 2012.

F3: The price in Column 4 is a weighted average price. The prices actually received ranged from $37.31 to $38.6325. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F4: Original option grant vested 6/48ths on November 12, 2011 and 1/48th on the 12th of every month thereafter.

F5: Original option grant vested 6/48ths on November 12, 2010 and 1/48th on the 12th of every month thereafter.

F6: Original option grant vested 6/48ths on November 12, 2009 and 1/48th on the 12th of every month thereafter.